Omeros Corporation — Balance Sheet (NASDAQ:OMER) | MetaTrader

Open full chart

Financials

Overview Finanzbericht Statistics Dividends

Quarterly Annual

Total assets 181.04 M419.27 M590.97 M378.27 M277.08 M Total liabilities 301.79 M395.49 M380.16 M268.56 M264.08 M Total equity 120.75 M23.78 M85.68 M24.98 M182.61 M Total liabilities & shareholders' equities 181.04 M419.27 M590.97 M378.27 M277.08 M Total debt ————— Net debt —————

Nachrichten

Omeros-Aktie legt nach Start der YARTEMLEA-Auslieferung zu

Omeros stock rises as first commercial YARTEMLEA shipments begin

Omeros begins commercial distribution of TA-TMA treatment Yartemlea

Omeros: Finanzvorstand Borges verkauft Aktien im Wert von 750.000 $/n

Omeros VP Borges sells $750k in shares

Omeros Corporation (OMER) Discusses FDA Approval and Commercialization Plans for YARTEMLEA in TA-TMA Treatment Transcript

Omeros Gets FDA Approval for YARTEMLEA as First Therapy for TA-TMA

Omeros: Why The Novo Nordisk Deal Is More Important Than FDA Approval (NASDAQ:OMER)

Biohaven, Omeros And Other Big Stocks Moving Lower In Friday's Pre-Market Session - Andersen Group (NYSE:ANDG), Biohaven (NYSE:BHVN)

Why Davis Commodities Shares Are Trading Higher By Over 5%; Here Are 20 Stocks Moving Premarket - AlphaTON Capital (NASDAQ:ATON), Biohaven (NYSE:BHVN)

NKE, OMER, MU, INTC, DVAX: 5 Trending Stocks Today - Nike (NYSE:NKE)

Omeros: Stock Pops On Yartemlea Approval, Longer-Term Upside Likely (NASDAQ:OMER)